Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,150 | 189 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,942 | 49 | $0 (2024) |
| Novo Nordisk Inc | $362.56 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $360.25 | 15 | $0 (2024) |
| Abbott Laboratories | $333.08 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $308.24 | 11 | $0 (2024) |
| PFIZER INC. | $236.81 | 15 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $199.82 | 4 | $0 (2024) |
| Lilly USA, LLC | $146.32 | 11 | $0 (2021) |
| Allergan, Inc. | $134.18 | 9 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $124.92 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,298 | 40 | AstraZeneca Pharmaceuticals LP ($642.33) |
| 2023 | $829.68 | 30 | AstraZeneca Pharmaceuticals LP ($329.98) |
| 2022 | $664.81 | 23 | AstraZeneca Pharmaceuticals LP ($305.54) |
| 2021 | $292.78 | 17 | Novo Nordisk Inc ($77.72) |
| 2020 | $302.95 | 13 | Astellas Pharma US Inc ($185.08) |
| 2019 | $726.70 | 20 | AstraZeneca Pharmaceuticals LP ($310.15) |
| 2018 | $360.49 | 18 | Horizon Pharma plc ($93.93) |
| 2017 | $674.47 | 28 | AstraZeneca Pharmaceuticals LP ($287.29) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Biological | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: Diabetes Care | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Respiratory | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Respiratory | ||||||
| 07/26/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes Care | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $65.42 | General |
| Category: Cardiovascular | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Respiratory | ||||||
| 06/06/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $111.63 | General |
| Category: Heart Failure | ||||||
| 06/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: RESPIRATORY | ||||||
| 06/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Biological | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: Respiratory | ||||||
| 05/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 377 | 1,063 | $149,265 | $88,280 |
| 2022 | 6 | 199 | 693 | $84,000 | $46,323 |
| 2021 | 9 | 286 | 904 | $117,550 | $66,799 |
| 2020 | 9 | 307 | 948 | $125,745 | $62,282 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 377 | $41,470 | $21,978 | 53.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 45 | 167 | $20,875 | $12,653 | 60.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 39 | 135 | $16,875 | $10,974 | 65.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 116 | $17,400 | $10,150 | 58.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 52 | 63 | $12,600 | $8,783 | 69.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 75 | $13,125 | $6,872 | 52.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 29 | 36 | $7,200 | $5,019 | 69.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 39 | $7,020 | $4,989 | 71.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $4,000 | $2,570 | 64.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 19 | $5,700 | $2,537 | 44.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 20 | $3,000 | $1,757 | 58.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 446 | $49,060 | $26,488 | 54.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 82 | $12,300 | $6,550 | 53.3% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 19 | 82 | $10,250 | $5,526 | 53.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 32 | $5,760 | $3,843 | 66.7% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 24 | 30 | $6,000 | $3,798 | 63.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 16 | 21 | $630.00 | $118.09 | 18.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 82 | 520 | $57,200 | $32,197 | 56.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 132 | $19,800 | $12,118 | 61.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 39 | 62 | $11,160 | $7,299 | 65.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 72 | $12,600 | $5,832 | 46.3% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 19 | 22 | $4,400 | $2,860 | 65.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 11 | 36 | $4,500 | $2,548 | 56.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 15 | $4,500 | $2,356 | 52.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 13 | 17 | $2,550 | $1,411 | 55.3% |
About Dr. Sana Abumeri, M.D
Dr. Sana Abumeri, M.D is a Internal Medicine healthcare provider based in Elyria, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669458709.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sana Abumeri, M.D has received a total of $5,150 in payments from pharmaceutical and medical device companies, with $1,298 received in 2024. These payments were reported across 189 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,150).
As a Medicare-enrolled provider, Abumeri has provided services to 1,169 Medicare beneficiaries, totaling 3,608 services with total Medicare billing of $263,684. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Elyria, OH
- Active Since 12/20/2005
- Last Updated 08/25/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1669458709
Products in Payments
- BREZTRI (Drug) $652.12
- FARXIGA (Drug) $554.07
- AIRSUPRA (Drug) $263.83
- Ozempic (Drug) $246.70
- MYRBETRIQ (Drug) $224.18
- ELIQUIS (Drug) $200.27
- AREXVY (Drug) $177.77
- CAMZYOS (Drug) $173.96
- LINZESS (Drug) $166.90
- BYDUREON (Drug) $159.82
- OPSUMIT (Drug) $124.92
- LOKELMA (Drug) $122.35
- TOUJEO (Drug) $118.58
- TRELEGY ELLIPTA (Drug) $115.51
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $111.63
- FREESTYLE LIBRE 2 (Device) $106.07
- SYMBICORT (Drug) $100.96
- CARDIOMEMS (Device) $96.89
- KRYSTEXXA (Drug) $93.93
- AFREZZA (Drug) $92.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elyria
Dr. Mehdi Shishehbor, Do, DO
Internal Medicine — Payments: $344,898
Ademola Abiose, Md, MD
Internal Medicine — Payments: $131,643
Dr. Norman Floro, Md, MD
Internal Medicine — Payments: $4,683
Vagesh Hampole, Md, MD
Internal Medicine — Payments: $1,521
Dr. Vijay Kakumanu, M.d, M.D
Internal Medicine — Payments: $1,393
Dr. Niraj Mistry, Md, MD
Internal Medicine — Payments: $1,172